Clinical trial
Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, &…
NCT00277017 · New Mexico Cancer Research Alliance, Other · Completed
Key facts
| NCT number | NCT00277017 |
|---|---|
| Title | Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma |
| Official title | A Phase I/II Trial of Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, and Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma. |
| Lead sponsor | New Mexico Cancer Research Alliance, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Kidney, Cancer |
| Intervention type | Drug |
| Interventions | 5-Flourouracil, Interferon-a, IL-2 and Thalidomide |
| Enrollment | 15 |
| Start date | Sep 1, 2000 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Jan 13, 2006 |
| Last update posted | Sep 27, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: